FOLD
Featured PickAmicus Therapeutics, Inc.
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
90
Entry Price
$14.49
Current Price
$14.49
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-24
Executive Summary
Amicus Therapeutics (FOLD) has just secured final regulatory clearance from the French Ministry of Economics and Finance, removing the last major hurdle for its $4.8 billion acquisition by BioMarin. This definitive M&A catalyst arrives in a highly supportive RISK_ON market regime where stable volatility and strong breadth reward aggressive positioning. With the final approval serving as the exact fundamental trigger, FOLD is perfectly positioned to transition from a quiet accumulation phase into a full momentum breakout.
Technical Context
Setup
The stock is consolidating perfectly at its 52-week high (+0.0%) on surging 1.5x relative volume, triggering rare ALPHA_MALE and QUIET_STORM signals that confirm heavy institutional demand.
Invalidation (Stop)
This momentum breakout setup is invalidated if the stock loses its structural support and closes below $14.41.
Runner-ups
Recent Performance History
56 Total Picks • 53% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | WAFD | $35.42 | $35.20 | -0.62% | N/A | N/A | N/A |
| 2026-04-22 | ASND | $231.05 | $229.27 | -0.77% | N/A | N/A | N/A |
| 2026-04-21 | DBRG | $15.61 | $15.60 | -0.06% | N/A | N/A | N/A |
| 2026-04-20 | WAFD | $35.20 | $35.20 | +0.00% | N/A | N/A | N/A |
| 2026-04-17 | WAFD | $35.24 | $35.20 | -0.11% | -0.11% | N/A | N/A |
| 2026-04-16 | WABC | $53.71 | $55.02 | +2.44% | +1.75% | N/A | N/A |
| 2026-04-15 | ASND | $241.71 | $229.27 | -5.15% | -4.41% | N/A | N/A |
| 2026-04-13 | ASND | $248.55 | $229.27 | -7.76% | -1.28% | N/A | N/A |
| 2026-04-10 | DBRG | $15.55 | $15.60 | +0.32% | +0.26% | N/A | N/A |
| 2026-04-09 | PKBK | $29.80 | $30.02 | +0.74% | -1.58% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0